Evolent Health (EVH) Long-Term Investments (2014 - 2026)

Evolent Health has reported Long-Term Investments for 13 years, with the latest figure at $9.0 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments fell 40.53% year-over-year to $9.0 million; the trailing twelve-month figure through Mar 2026 stood at $9.0 million (down 40.53% YoY), and the FY2025 full-year result was $9.0 million, down 40.22% from the prior year.
• Long-Term Investments for Q1 2026 stood at $9.0 million, roughly flat from $9.0 million in the prior quarter.
• The five-year high for Long-Term Investments was $16.9 million in Q4 2023, with the low at $2.6 million in Q2 2025.
• Average Long-Term Investments over 5 years is $8.6 million, with a median of $8.4 million recorded in 2024.
• Year-over-year, Long-Term Investments jumped 276.85% in 2023 and slumped 68.86% in 2025.
• Tracing EVH's Long-Term Investments over 5 years: stood at $4.5 million in 2022, then jumped by 276.85% to $16.9 million in 2023, then retreated by 11.06% to $15.0 million in 2024, then tumbled by 40.22% to $9.0 million in 2025, then decreased by 0.12% to $9.0 million in 2026.
• The last three Long-Term Investments figures came in at $9.0 million (Q1 2026), $9.0 million (Q4 2025), and $8.9 million (Q3 2025), per Business Quant data.

Peer Comparison